Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Freeline Therapeutics Holdings (FRLN)
NASDAQ:FRLN
RESEARCH TOOLSreports
Holding FRLN?
Track your performance easily
See the Price Targets and Ratings of:
FRLN Analyst Ratings
Hold
0 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
FRLN Stock 12 Month Forecast
Average Price Target
$6.50
▲(0.31% Upside)
| Highest Price Target$6.50 | Average Price Target$6.50 | Lowest Price Target$6.50 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Stifel Nicolaus
Reiterated
11/29/23
H.C. Wainwright
Downgraded
11/28/23
Wedbush
$5
Hold
-22.84%
Downside
Downgraded
10/18/23
Freeline downgraded to Neutral from Outperform at WedbushFreeline downgraded to Neutral from Outperform at Wedbush
BTIG
$30
Buy
362.96%
Upside
Reiterated
04/05/23
BTIG Remains a Buy on Freeline Therapeutics Holdings (FRLN)
Best Analysts Covering Freeline Therapeutics Holdings
Which Analyst Should I Follow If I Want to Buy FRLN and Sell After:
1 Month
xxx
Success Rate
2/9 ratings generated profit
Average Return
-16.86%
reiterated a xxx
rating 2 years ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 22.22% of your transactions generating a profit, with an average return of -16.86% per trade.
3 Months
xxx
Success Rate
1/9 ratings generated profit
Average Return
-28.52%
reiterated a xxx
rating 2 years ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 11.11% of your transactions generating a profit, with an average return of -28.52% per trade.
1 Year
2 Years
xxx
Success Rate
0/9 ratings generated profit
Average Return
-52.82%
reiterated a xxx
rating 2 years ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -52.82% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
FRLN Analyst Recommendation Trends
Rating
Apr 23
May 23
Aug 23
Oct 23
Nov 23
Strong Buy
6
7
6
6
4
Buy
1
0
0
0
0
Hold
1
2
3
4
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
8
9
9
10
9
Each month's total comprises the sum of three months' worth of ratings.
FRLN Financial Forecast
FRLN Stock Forecast FAQ
What is FRLN’s average 12-month price target, according to analysts?
Based on analyst ratings, Freeline Therapeutics Holdings’s 12-month average price target is $6.50.
What is FRLN’s upside potential, based on the analysts’ average price target?
Freeline Therapeutics Holdings has 0.31% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is FRLN a Buy, Sell or Hold?
Freeline Therapeutics Holdings has a consensus rating of Hold which is based on 0 buy ratings, 2 hold ratings and 0 sell ratings.
What is Freeline Therapeutics Holdings’s price target?
The average price target for Freeline Therapeutics Holdings is $6.50. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $6.50 ,the lowest forecast is $6.50. The average price target represents 0.31% Increase from the current price of $6.48.
The highest analyst price target is $6.50 ,the lowest forecast is $6.50. The average price target represents 0.31% Increase from the current price of $6.48.
What do analysts say about Freeline Therapeutics Holdings?
Freeline Therapeutics Holdings’s analyst rating consensus is a Hold. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of FRLN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.